Strata Critical Medical, Inc.
SRTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $249 | $225 | $146 | $51 |
| % Growth | 10.4% | 54.1% | 189.2% | – |
| Cost of Goods Sold | $190 | $183 | $124 | $40 |
| Gross Profit | $59 | $42 | $22 | $11 |
| % Margin | 23.7% | 18.7% | 15.2% | 20.8% |
| R&D Expenses | $3 | $5 | $6 | $2 |
| G&A Expenses | $82 | $95 | $63 | $30 |
| SG&A Expenses | $90 | $106 | $70 | $33 |
| Sales & Mktg Exp. | $8 | $10 | $8 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $93 | $110 | $76 | $35 |
| Operating Income | -$34 | -$68 | -$54 | -$24 |
| % Margin | -13.6% | -30.3% | -36.6% | -47.7% |
| Other Income/Exp. Net | $6 | $11 | $25 | -$20 |
| Pre-Tax Income | -$28 | -$58 | -$28 | -$44 |
| Tax Expense | -$0 | -$1 | -$1 | -$4 |
| Net Income | -$27 | -$56 | -$27 | -$40 |
| % Margin | -11% | -24.9% | -18.7% | -79.3% |
| EPS | -0.35 | -0.76 | -0.38 | -0.57 |
| % Growth | 53.9% | -100% | 33.3% | – |
| EPS Diluted | -0.35 | -0.76 | -0.38 | -0.57 |
| Weighted Avg Shares Out | 77 | 74 | 71 | 70 |
| Weighted Avg Shares Out Dil | 77 | 74 | 71 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $8 | $3 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $7 | -$16 | $1 |
| EBITDA | -$28 | -$61 | -$70 | -$23 |
| % Margin | -11.2% | -27.1% | -47.8% | -46.5% |